Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

378 indexed citations
published 1978
Journal
Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

In The Last Decade

doi.org/w8398076 →

Countries where authors are citing Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Specialization
Citations

This map shows the geographic impact of Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. more than expected).

Fields of papers citing Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine..

About Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

This paper, published in 1978, received 378 indexed citations . Written by P. Sharon, M. Ligumsky, Daniel Rachmilewitz and U. Zor covering the research area of Oncology, Surgery and Pharmacology. It is primarily cited by scholars working on Surgery (167 citations), Pharmacology (165 citations) and Genetics (159 citations). Published in Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w8398076.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026